These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 8219655)
1. Systemic vasculitis positive for circulating anti-neutrophil cytoplasmic antibodies and with predominantly neurological presentation. Stumvoll M; Schnauder G; Overkamp D; Buettner UW; Grodd W; Eggstein M Clin Investig; 1993 Aug; 71(8):613-5. PubMed ID: 8219655 [TBL] [Abstract][Full Text] [Related]
2. Use of antineutrophil cytoplasmic autoantibodies in diagnosing vasculitis in a Chinese patient population. Li PK; Leung JC; Lai FM; Wang A; Lui SF; Leung CB; Lai KN Am J Nephrol; 1994; 14(2):99-105. PubMed ID: 7915885 [TBL] [Abstract][Full Text] [Related]
3. Anti-neutrophil cytoplasmic auto antibodies (ANCA) in Pakistani patients with systemic vasculitides. Ahmed TA; Malik IA; Khan AA; Shah ST; Hameed A; Haleem SA; Farooqui A; Amin SJ J Pak Med Assoc; 1994 Dec; 44(12):272-5. PubMed ID: 7861580 [TBL] [Abstract][Full Text] [Related]
4. Anti-neutrophil cytoplasm antibodies (ANCA). Savige JA; Davies DJ Aust N Z J Med; 1990 Jun; 20(3):271-4. PubMed ID: 2196872 [TBL] [Abstract][Full Text] [Related]
5. Value of anti-neutrophil cytoplasmic autoantibodies and other laboratory parameters in follow-up of vasculitis. Halma C; Daha MR; Schrama E; Hermans J; van Es LA; van der Woude FJ Scand J Rheumatol; 1990; 19(6):392-7. PubMed ID: 2259895 [TBL] [Abstract][Full Text] [Related]
6. Titration of antibodies against neutrophil cytoplasmic antigens is useful in monitoring disease activity in systemic vasculitides. Egner W; Chapel HM Clin Exp Immunol; 1990 Nov; 82(2):244-9. PubMed ID: 1978703 [TBL] [Abstract][Full Text] [Related]
7. What is new with anti-neutrophil cytoplasmic antibodies: diagnostic, pathogenetic and therapeutic implications. Kallenberg CG; Tervaert JW Curr Opin Nephrol Hypertens; 1999 May; 8(3):307-15. PubMed ID: 10456261 [TBL] [Abstract][Full Text] [Related]